Sartorius strengthens product portfolio for cell and gene therapies by acquiring a majority stake in CellGenix ...Middle East

GÖTTINGEN, Germany, July 2, 2021 /PRNewswire/ -- The life science group Sartorius, through its subgroup Sartorius Stedim Biotech, has acquired a majority stake in the reagent manufacturer CellGenix GmbH. The company based in Freiburg, Germany, and with a sales subsidiary near the...

Hence then, the article about sartorius strengthens product portfolio for cell and gene therapies by acquiring a majority stake in cellgenix was published today ( Friday 02/07/2021 - 03:31 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sartorius strengthens product portfolio for cell and gene therapies by acquiring a majority stake in CellGenix )

Also on site :

• CGTN : l'agenda national de la Chine : principales priorités à la suite des inspections de Xi Jinping et des réunions organisées en 2025
• Protests Push Iran Into a New Phase of Turmoil
• TennRich étend l'écosystème de l'alimentation portable Energizer® à toute l'Europe avec une disponibilité immédiate des stocks